DULCINEA QUINTANA MD
Prescription History 1912046921
Internal Medicine in Albuquerque, NM
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DULCINEA QUINTANA MD, an active Internal Medicine specialist practicing in Albuquerque, NM. Our medical registry currently tracks 17 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 323 documented patient claims. Among these therapy options, the most frequently utilized medication is Jakafi, which accounts for 49 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NM PrescribersVs. NM Avg |
|---|---|---|---|
| JakafiRuxolitinib Phosphate | 49 | $18,851.61 | ▲ More than typical |
About Jakafi: This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). Show more ▾ It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 49 Medicare prescriptions for Jakafi, about 2.1 times the volume of the typical New Mexico prescriber of this medication (23). Medicare paid an average of $18,851.61 per fill, versus $17,121.82 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 49 30-Day Fills standardized to 30-day supplies 1,470 Days of Medication total across all patients in 2023 | |||
| Acyclovir | 30 | $15.78▼ below NM avg | ▲ More than typical |
About Acyclovir: Acyclovir is used to treat infections caused by certain types of viruses. Show more ▾ It treats cold sores around the mouth (caused by herpes simplex), shingles (caused by herpes zoster), and chickenpox. This medication is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Acyclovir is an antiviral drug. However, it is not a cure for these infections. The viruses that cause these infections continue to live in the body even between outbreaks. Acyclovir decreases the severity and length of these outbreaks. It helps the sores heal faster, keeps new sores from forming, and decreases pain/itching. This medication may also help reduce how long pain remains after the sores heal. In addition, in people with a weakened immune system, acyclovir can decrease the risk of the virus spreading to other parts of the body and causing serious infections. A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. In 2023, this provider wrote 30 Medicare prescriptions for Acyclovir, about 1.3 times the volume of the typical New Mexico prescriber of this medication (23). Medicare paid an average of $15.78 per fill, versus $23.11 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 30 | $14,566.30 | ▲ More than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 30 Medicare prescriptions for Lenalidomide, about 2.1 times the volume of the typical New Mexico prescriber of this medication (14). Medicare paid an average of $14,566.30 per fill, versus $13,588.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 24 | $13.72▼ below NM avg | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 24 Medicare prescriptions for Dexamethasone, about the same volume as the typical New Mexico prescriber of this medication (26). Medicare paid an average of $13.72 per fill, versus $14.21 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 24 30-Day Fills standardized to 30-day supplies 471 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 21 | $20.05▼ below NM avg | ▼ Less than typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 21 Medicare prescriptions for Hydroxyurea, about 60% of the volume of the typical New Mexico prescriber of this medication (35). Medicare paid an average of $20.05 per fill, versus $43.87 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,007 Days of Medication total across all patients in 2023 | |||
| PomalystPomalidomide | 19 | $16,700.38▼ below NM avg | ≈ Typical |
About Pomalyst: Pomalidomide is used to treat certain types of cancers (such as multiple myeloma, Kaposi sarcoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 19 Medicare prescriptions for Pomalyst, about the same volume as the typical New Mexico prescriber of this medication (18). Medicare paid an average of $16,700.38 per fill, versus $20,596.08 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 19 30-Day Fills standardized to 30-day supplies 532 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 17 | $8.90▼ below NM avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 17 Medicare prescriptions for Gabapentin, about 18% of the volume of the typical New Mexico prescriber of this medication (93). Medicare paid an average of $8.90 per fill, versus $18.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Tranexamic Acid | 17 | $129.18 | ≈ Typical |
About Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage. In 2023, this provider wrote 17 Medicare prescriptions for Tranexamic Acid, about the same volume as the typical New Mexico prescriber of this medication (16). Medicare paid an average of $129.18 per fill, versus $54.78 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 155 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $4.79▼ below NM avg | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 16 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about 73% of the volume of the typical New Mexico prescriber of this medication (22). Medicare paid an average of $4.79 per fill, versus $5.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 16 30-Day Fills standardized to 30-day supplies 440 Days of Medication total across all patients in 2023 | |||
| RevlimidLenalidomide | 14 | $18,185.91 | ▼ Less than typical |
About Revlimid: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 14 Medicare prescriptions for Revlimid, about a third of the volume of the typical New Mexico prescriber of this medication (35). Medicare paid an average of $18,185.91 per fill, versus $17,473.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 13 | $13.15▼ below NM avg | ▼ Less than typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 13 Medicare prescriptions for Allopurinol, about a third of the volume of the typical New Mexico prescriber of this medication (39). Medicare paid an average of $13.15 per fill, versus $16.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 25 30-Day Fills standardized to 30-day supplies 732 Days of Medication total across all patients in 2023 | |||
| VenclextaVenetoclax | 13 | $5,662.00▼ below NM avg | ▼ Less than typical |
About Venclexta: This medication is used to treat certain types of cancer (chronic lymphocytic leukemia-CLL, small lymphocytic lymphoma-SLL, acute myeloid leukemia-AML). Show more ▾ Venetoclax is a drug that works by helping to slow or stop the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Venclexta, about 65% of the volume of the typical New Mexico prescriber of this medication (20). Medicare paid an average of $5,662.00 per fill, versus $11,557.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 13 30-Day Fills standardized to 30-day supplies 321 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 13 | $1,596.92 | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 13 Medicare prescriptions for Xarelto, about a third of the volume of the typical New Mexico prescriber of this medication (42). Medicare paid an average of $1,596.92 per fill, versus $901.52 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37 30-Day Fills standardized to 30-day supplies 1,110 Days of Medication total across all patients in 2023 | |||
| ImbruvicaIbrutinib | 12 | $17,020.75 | ▼ Less than typical |
About Imbruvica: This medication is used to treat certain cancers (such as mantle cell or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenstrom's macroglobulinemia). Show more ▾ Ibrutinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. Ibrutinib is also used to treat a certain problem that may occur after a stem cell transplant (chronic graft versus host disease). It works by weakening your body's defense system (immune system). In 2023, this provider wrote 12 Medicare prescriptions for Imbruvica, about half the volume of the typical New Mexico prescriber of this medication (26). Medicare paid an average of $17,020.75 per fill, versus $14,504.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 336 Days of Medication total across all patients in 2023 | |||
| Omeprazole | 12 | $13.41▼ below NM avg | ▼ Less than typical |
About Omeprazole: Omeprazole is used to treat certain stomach and esophagus problems (such as acid reflux, ulcers). Show more ▾ It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as heartburn, difficulty swallowing, and cough. This medication helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Omeprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). If you are self-treating with this medication, over-the-counter omeprazole products are used to treat frequent heartburn (occurring 2 or more days a week). Since it may take 1 to 4 days to have full effect, these products do not relieve heartburn right away. For over-the-counter products, carefully read the package instructions to make sure the product is right for you. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar brand names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. In 2023, this provider wrote 12 Medicare prescriptions for Omeprazole, about 16% of the volume of the typical New Mexico prescriber of this medication (74). Medicare paid an average of $13.41 per fill, versus $17.68 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 26 30-Day Fills standardized to 30-day supplies 780 Days of Medication total across all patients in 2023 | |||
| SprycelDasatinib | 12 | $16,424.80 | ≈ Typical |
About Sprycel: This medication is used to treat certain types of cancer (chronic myeloid leukemia-CML, acute lymphoblastic leukemia-ALL). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB. In 2023, this provider wrote 12 Medicare prescriptions for Sprycel, about the same volume as the typical New Mexico prescriber of this medication (13). Medicare paid an average of $16,424.80 per fill, versus $12,330.10 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 11 | $687.00▼ below NM avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 11 Medicare prescriptions for Eliquis, about 20% of the volume of the typical New Mexico prescriber of this medication (56). Medicare paid an average of $687.00 per fill, versus $795.53 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NM prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NM average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DULCINEA QUINTANA MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Internal Medicine prescribing approach at this Albuquerque, NM practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NM prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
